Highlights
- •Symptoms that might indicate heart disease are common in primary care patients.
- •Chest pain/discomfort is the most prevalent symptom in the diabetic patients.
- •Ischemic heart disease was diagnosed in 15 % of the referred diabetic patients.
- •The yield of specific diagnoses is low compared to the diagnostic tests applied.
Abstract
Aims
Methods
Results
Conclusions
Keywords
1. Introduction
- Roth G.A.
- Mensah G.A.
- Johnson C.O.
- et al.
- Roth G.A.
- Mensah G.A.
- Johnson C.O.
- et al.
- Lin X.
- Xu Y.
- Pan X.
- et al.
- Booth G.L.
- Kapral M.K.
- Fung K.
- Tu J. v
2. Methods
Statistics Finland’s free-of-charge statistical databases, Municipalities and population numbers by municipality 2000–2020, (n.d.). 〈https://www.kuntaliitto.fi/haku?s=asukasluvut+kunnittain+2000–2020〉 (accessed May 10, 2022).
3. Statistical analysis
4. Results
4.1 Patient characteristics
Diabetes mellitus Not present N = 584 | Diabetes mellitus Present N = 120 | P-value | |
---|---|---|---|
Medical history, n (%) | |||
Cerebrovascular disease | 24 (4) | 7 (6) | 0.85 |
Hypertension | 251 (43) | 84 (70) | <0.001 |
Atrial fibrillation | 99 (17) | 20 (17) | 0.94 |
Familial hypercholesterolemia | 2 (0) | 0 (0) | 0.99 |
Depression | 40 (7) | 12 (10) | 0.23 |
Rheumatoid arthritis | 26 (4) | 5 (4) | 0.89 |
Obstructive sleep apnoea | 25 (4) | 15 (13) | <0.001 |
Risk factors | |||
Smoking status, n (%) | 0.15 | ||
Never smoked | 510 (87) | 98 (82) | |
Current smoker | 39 (7) | 14 (12) | |
Ex-smoker | 35 (6) | 8 (7) | |
Family history of CAD, n (%) | 115 (20) | 12 (10) | 0.012 |
Home blood pressure, mmHg, mean (SD) | [287] | [66] | |
Systolic | 134 (17) | 134 (14) | 0.69 |
Diastolic | 78 (10) | 79 (11) | 0.45 |
Office blood pressure, mmHg, mean (SD) | [408] | [83] | |
Systolic | 146 (23) | 146 (18) | 0.95 |
Diastolic | 84 (12) | 84 (11) | 0.86 |
Body mass index, kg/m2, mean (SD) | 28.6 (5.8) [156] | 32.9 (9.4) [53] | <0.001 |
Fasting plasma lipids, mmol/l, mean (SD) | |||
Total cholesterol | 5.24 (1.11) [405] | 4.49 (1.01) [108] | <0.001 |
HDL cholesterol | 1.66 (0.49) [399] | 1.36 (0.42) [108] | <0.001 |
LDL cholesterol | 3.01(0.99) [393] | 2.45 (0.83) [108] | <0.001 |
Triglycerides | 1.28 (0.79) [397] | 1.52 (0.66) [108] | <0.001 |
Fasting plasma glucose, mmol/l, mean (SD) | 5.72 (0.65) [437] | 7.72 (2.17)[13] | 0.004 |
eGFR, ml/min/1.73 m2, mean (SD) | 73.8 (23.2) [469] | 75.4 (19.4) [111] | 0.50 |
Current medication, n (%) | |||
Statin | 161 (28) | 66 (55) | <0.001 |
Beta-blocker | 225 (39) | 40 (33) | 0.28 |
Calcium-channel blocker | 96 (16) | 30 (25) | 0.026 |
ACE inhibitor or Angiotensin-receptor antagonist | 185 (32) | 65 (54) | <0.001 |
Diuretics | 80 (14) | 34 (28) | <0.001 |
Nitrates | 60 (10) | 13 (11) | 0.006 |
Clopidogrel | 9 (2) | 1 (1) | 0.99 |
Acetylsalicylic acid | 29 (5) | 13 (11) | 0.013 |
Warfarin or new oral anticoagulant | 82 (14) | 26 (22) | 0.035 |
4.2 Symptoms and signs

4.3 Diagnostic tests applied
Diabetes mellitus Not presentn= 584 | Diabetes mellitus Present n = 120 | P-value | |
---|---|---|---|
Echocardiography, n (%) | 300 (51) | 61 (51) | 0.91 |
Exercise ECG n, n (%) | 244 (42) | 58 (48) | 0.19 |
Exercise ECG with isotope perfusion imaging, n (%) | 3 (1) | 0 (0) | 0.98 |
Stress echocardiography, n (%) | 4 (1) | 0 (0) | 0.95 |
Coronary computed tomographic angiography, n (%) | 32 (5) | 13 (11) | 0.029 |
Invasive coronary angiography, n (%) | 14 (2) | 5 (4) | 0.28 |
Ambulatory ECG monitoring, n (%) | 274 (47) | 44 (37) | 0.040 |
None, n (%) | 14 (2) | 3 (3) | 0.95 |
Diabetes mellitus Not present | P-value | Diabetes mellitus Present | P-value | |
---|---|---|---|---|
OR (95 % CI) | OR (95 % CI) | |||
Sense of arrhythmia | 1.70 (1.04–2.77) | 0.033 | 4.46 (1.29–15.44) | 0.018 |
Chest pain/discomfort | 0.40 (0.25–0.64) | <0.001 | 0.66 (0.22–2.01) | 0.47 |
Exertional dyspnea | 0.92 (0.58–1.45) | 0.72 | 0.60 (0.18–1.94) | 0.39 |
Referred pain | 1.91 (0.92–3.98) | 0.083 | 15.37 (1.60 to >50.0) | 0.018 |
Dizziness/syncope | 0.50 (0.22–1.10) | 0.086 | 0.36 (0.06–2.20) | 0.27 |
Symptomless pathological electrocardiogram | 0.90 (0.38–2.14) | 0.81 | 1.90 (0.36–10.14) | 0.45 |
Nausea | 0.85 (0.42–1.74) | 0.66 | 0.60 (0.07–4.84) | 0.63 |
Effort intolerance | 0.61 (0.24–1.55) | 0.30 | 0.58 (0.05–6.26) | 0.66 |
Sweating | 0.47 (0.12–1.84) | 0.28 | 4.10 (0.35–47.34) | 0.26 |
4.4 Diagnosis
5. Discussion
Diabetes mellitus Not presentn= 650 | Diabetes mellitus Presentn= 120 | |
---|---|---|
None, n (%) | 90 (14) | 15 (13) |
Hypertension (I10-I11), n (%) | 48 (7) | 10 (8) |
Ischemic heart disease (I20-I25), n (%) | 38 (6) | 18 (15) |
Arrythmias, n (%) Atrial fibrillation/flutter (I48) | 170 (26) 72 (11) | 24 (20) 13 (11) |
Respiratory disease (J00-J99), n (%) | 5 (1) | 2 (2) |
Other, n (%) Nonrheumatic aortic valve disorders (I35.9) Hypertensive heart disease (I11.0) Atrioventricular and left bundle-branch block (I44) Mitral (valve) insufficiency (I34.0) Other conduction disorders (I45) Cardiomyopathy (I42) | 51 (8) 19 (3) 10 (2) 7 (1) 7 (1) 6 (1) 5 (1) | 12 (10) 5 (4) 1 (1) 2 (2) 1 (1) 2 (2) 1 (1) |
Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified, n (%) R00 Abnormalities of heartbeat R07 Pain in throat and chest R06 Dyspnea R55 Syncope and collapse | 182 (28) 46 (7) 81 (12) 32 (5) 12 (2) | 39 (33) 10 (8) 18 (15) 10 (8) 5 (4) |
ESC GUIDELINES 2013 ESC guidelines on the management of stable coronary artery disease, (n.d.). https://doi.org/10.1093/eurheartj/eht296.
- Douglas P.S.
- Hoffmann U.
- Patel M.R.
- et al.
ESC GUIDELINES 2013 ESC guidelines on the management of stable coronary artery disease, (n.d.). https://doi.org/10.1093/eurheartj/eht296.
the M.A.B. of the F.D.S, Working group appointed by the Finnish Medical Society Duodecim, the Finnish Society of Internal Medicine, Curr. Care Guidel. of Chronic coronary syndrome published: 28.06.2022 |〈https://www.kaypahoito.fi/hoi50056〉.
- Douglas P.S.
- Hoffmann U.
- Patel M.R.
- et al.
Funding
Declaration of Competing Interest
References
- Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study.J. Am. Coll. Cardiol. 2020; https://doi.org/10.1016/j.jacc.2020.11.010
- Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.Sci. Rep. 2020; 10https://doi.org/10.1038/s41598-020-71908-9
- Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.Cardiovasc Diabetol. 2018; 17: 83https://doi.org/10.1186/s12933-018-0728-6
- Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study.Lancet. 2006; https://doi.org/10.1016/S0140-6736(06)68967-8
Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 10th Edition (online access included), ProtoView. 2 (2015).
- Asymptomatic coronary artery disease in type II diabetes.Mo Med. 2014; 111 (/pmc/articles/PMC6179518/ (accessed May 9, 2022)): 73
- Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic SubjectsThe DIAD study.Diabetes Care. 2004; 27: 1954-1961https://doi.org/10.2337/DIACARE.27.8.1954
Statistics Finland’s free-of-charge statistical databases, Municipalities and population numbers by municipality 2000–2020, (n.d.). 〈https://www.kuntaliitto.fi/haku?s=asukasluvut+kunnittain+2000–2020〉 (accessed May 10, 2022).
- Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses.Heart. 2017; 103: 1727-1732https://doi.org/10.1136/heartjnl-2016-310905
ESC GUIDELINES 2013 ESC guidelines on the management of stable coronary artery disease, (n.d.). https://doi.org/10.1093/eurheartj/eht296.
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC).Eur. Heart J. 2020; 41: 407-477https://doi.org/10.1093/EURHEARTJ/EHZ425
- Incorporating coronary calcification into pre-test assessment of the likelihood of coronary artery disease.J. Am. Coll. Cardiol. 2020; 76: 2421-2432https://doi.org/10.1016/J.JACC.2020.09.585
- Outcomes of anatomical versus functional testing for coronary artery disease.N. Engl. J. Med. 2015; 372: 1291-1300https://doi.org/10.1056/NEJMOA1415516/SUPPL_FILE/NEJMOA1415516_DISCLOSURES.PDF
- The Western Denmark heart registry: its influence on cardiovascular patient care.J. Am. Coll. Cardiol. 2018; 71: 1259-1272https://doi.org/10.1016/J.JACC.2017.10.110
- PROspective multicenter imaging study for evaluation of chest pain: rationale and design of the PROMISE trial.Am. Heart J. 2014; 167 (e1): 796-803https://doi.org/10.1016/J.AHJ.2014.03.003
- Symptoms as the main problem in primary care: a cross-sectional study of frequency and characteristics.Scand. J. Prim. Health Care. 2015; 33: 91https://doi.org/10.3109/02813432.2015.1030166
the M.A.B. of the F.D.S, Working group appointed by the Finnish Medical Society Duodecim, the Finnish Society of Internal Medicine, Curr. Care Guidel. of Chronic coronary syndrome published: 28.06.2022 |〈https://www.kaypahoito.fi/hoi50056〉.
Article info
Publication history
Identification
Copyright
User license
Creative Commons Attribution (CC BY 4.0) |
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy